Skip to main navigation Skip to search Skip to main content

An Open-label, Multi-center, Long-term Extension Study of Zanubrutinib (BGB-3111) in Patients with B-cell Malignancies

Project: Research

Project Details

StatusFinished
Effective start/end date13/08/20 → 12/08/25

Keywords

  • clinical trial
  • treatment efficacy
  • lymphoma
  • leukemia
  • treatment safety

Clinical Trial Phase

  • Phase III (a & b)